GSK says U.S. FDA approves Boostrix for immunization during pregnancy
October 10, 2022 at 02:18 AM EDT
The vaccine is also indicated against tetanus, diphtheria and pertussis in individuals aged 10 years and older, GSK said.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
